Fundz

Aligos Therapeutics reported raising $105 Million in an initial SEC Form D filing, from an offering of $105 Million

PUBLIC · ALGSFeb 28, 2025

Amount Raised

$105 Million

$105 Million sold, per SEC Form D (first sale Feb 11, 2025)

Round Type

Venture

South San FranciscoBiotechnologyHealth CareTherapeuticsBiopharma

Quick answer

Aligos Therapeutics raised $105 Million in a funding round, dated February 11, 2025. Aligos Therapeutics is based in South San Francisco, California, United States.

How much did Aligos Therapeutics raise?
Aligos Therapeutics raised $105 Million in a funding round on February 11, 2025.
What does Aligos Therapeutics do?
Aligos is a biopharmaceutical company developing targeted therapeutics to address unmet medical needs in liver and viral diseases including MASH, CHB and COVID-19.
Where is Aligos Therapeutics based and how big is it?
Aligos Therapeutics is based in South San Francisco, California, United States. Fundz records about 82 employees.
Who are the decision-makers at Aligos Therapeutics?
Fundz holds 2 contacts at Aligos Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biopharma around the same time

Companies in the same sectors as Aligos Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Tempero Bio raised $70M (Series B) on March 24, 2025.
  • Lipella Pharmaceuticals raised $9K (Seed) on March 17, 2025.
  • Acasti raised $15M on February 10, 2025.
  • NRx Pharmaceuticals raised $3.5M (Seed) on January 27, 2025.
  • Windward Bio raised $200M (Series A) on January 10, 2025.
  • Verdiva Bio raised $411M (Series A) on January 9, 2025.

Who to call at Aligos Therapeutics, and when

A new round usually means Aligos Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Aligos Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Aligos Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Aligos Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Aligos Therapeutics

Location

One Corporate Dr., 2nd Floor

South San Francisco, California, United States

About

Aligos is a biopharmaceutical company developing targeted therapeutics to address unmet medical needs in liver and viral diseases including MASH, CHB and COVID-19.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Aligos Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Predictive Intelligence
Strategic

ML-powered predictions for Aligos Therapeutics's next move

See what Strategic adds

Aligos Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.